ACS Medicinal Chemistry Letters, published by the American Chemical Society, is a distinguished journal dedicated to advancing the field of medicinal chemistry. With impressive rankings in the 2023 category quartiles—Q1 in Drug Discovery and Organic Chemistry as well as Q2 in Biochemistry—this journal serves as a vital platform for researchers seeking to publish innovative findings and methodologies in drug development and therapeutic advancements. The journal's notable impact is reflected in its Scopus rankings, where it stands at #43 in Organic Chemistry and #45 in Drug Discovery. Although it does not currently offer open access, the contributions published from 2010 to 2024 provide a wealth of knowledge critical to both academia and industry. As a key resource for students, professionals, and researchers in the fields of chemistry and pharmacology, ACS Medicinal Chemistry Letters plays an essential role in shaping the future of medicinal therapeutics.

SYNTHESIS-STUTTGART

Published by the esteemed Georg Thieme Verlag KG, SYNTHESIS-STUTTGART stands as a vital resource in the field of Chemistry, specifically focusing on Organic Chemistry and Catalysis. With an impressive publication history dating back to 1970 and continuing through 2024, it serves as a platform for innovative research and developments in synthetic methodologies and their applications. The journal holds a significant impact factor, reflecting its influence within the academic community, and is recognized in the Scopus rankings as a reputable source in its categories, with a rank of #99/211 in Organic Chemistry and #43/68 in Catalysis. Researchers, professionals, and students alike can benefit greatly from its content, which upholds rigorous peer-review standards and contributes to the global discourse in these critical scientific domains.

Heteroatom Chemistry is a prominent open-access journal dedicated to advancing the field of heteroatom chemistry, with a particular focus on the chemistry of elements other than carbon in organic compounds. Published by Wiley-Hindawi, this journal provides researchers, professionals, and students with a platform to disseminate and access novel research findings related to the synthesis, properties, and applications of heteroatom-containing compounds. Since its inception in 1990 and gaining open access status in 2019, the journal has fostered academic collaboration and innovation throughout its converged years, although it currently holds a category quartile ranking of Q4 in Chemistry (miscellaneous) and ranks #319 out of 408 in general chemistry within Scopus. With its commitment to high-quality research and broad accessibility, Heteroatom Chemistry is poised to be an essential resource for anyone looking to explore the rich and varied applications of heteroatom chemistry in diverse scientific fields.

Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.

JOURNAL OF SYNTHETIC ORGANIC CHEMISTRY JAPAN, published by the SOCIETY OF SYNTHETIC ORGANIC CHEMISTRY, JAPAN, is an esteemed publication specializing in the dynamic field of organic chemistry. With a rich history dating back to 1944, this journal aims to disseminate pivotal research findings and innovative methodologies in synthetic organic chemistry, fostering collaboration and knowledge exchange among researchers and professionals. Although it currently holds a modest ranking in the Q4 quartile for organic chemistry, its commitment to advancing the discipline remains steadfast. The journal primarily caters to scholars and students seeking to delve deeper into organic synthesis, highlighting original articles, reviews, and methodological studies. While access to the journal is not open, its contributions to the field are essential for anyone invested in understanding the complexities of organic chemistry. We invite you to explore the journal's offerings and enhance your expertise in synthetic organic processes.

Research Journal of Pharmacognosy, published by the Iranian Society of Pharmacognosy, is a pioneering forum for the dissemination of research in the field of pharmacognosy and its related disciplines. Founded in 2014 as an Open Access journal, it aims to provide swift and free access to high-quality research articles, fostering collaboration and innovation among researchers, professionals, and students. Operating from Tehran, Iran, this journal addresses a wide range of topics including complementary and alternative medicine, drug discovery, and organic chemistry, making it an invaluable resource for those researching the extraction, characterization, and application of naturally derived compounds. The journal holds a Category Quartile ranking of Q3 in Complementary and Alternative Medicine and Q4 in both Drug Discovery and Organic Chemistry for the year 2023, which underscores its growing influence within the scientific community. By serving as a platform for current advances and thought leadership in pharmacognosy, the Research Journal of Pharmacognosy plays a crucial role in bridging the gap between traditional practices and modern pharmacological applications.

BIOORGANIC & MEDICINAL CHEMISTRY, published by Pergamon-Elsevier Science Ltd, is a prominent journal in the fields of biochemical research and drug discovery, with an ISSN of 0968-0896 and an E-ISSN of 1464-3391. Established in 1993, it has garnered respect and recognition, evidenced by its categorization in various quartile ranks across 2023, including Q2 in Clinical Biochemistry and Pharmaceutical Science. It holds significant Scopus rankings, placing it in the 75th percentile in Pharmaceutical Science and 74th percentile in Organic Chemistry, highlighting its influential contributions to ongoing research and developments. This journal provides a platform for disseminating advancements in bioorganic and medicinal chemistry, focusing on innovative methodologies, therapeutic advancements, and molecular pharmacology. Although it does not follow an open-access model, it remains a key resource for researchers, professionals, and students aiming to stay at the forefront of scientific discovery in the UK and beyond. The journal’s commitment to enhancing knowledge within the biomedical community makes it an essential read for those passionate about this dynamic field.

CURRENT ORGANIC SYNTHESIS, published by Bentham Science Publishers Ltd, is a leading journal in the field of organic chemistry and biochemistry that serves as a vital platform for researchers and professionals advancing the synthesis of organic compounds. With an ISSN of 1570-1794 and an E-ISSN of 1875-6271, it boasts a significant impact within its category, ranked in the Q3 quartile for both biochemistry and organic chemistry as of 2023. The journal covers innovative research and reviews that enhance our understanding of organic synthesis methodologies, showcasing contributions that advance the field. Operating from Sharjah, United Arab Emirates, CURRENT ORGANIC SYNTHESIS has evolved since its inception in 2005, providing access to a wealth of information essential for students, professionals, and researchers alike. While it currently does not offer open access, the journal continues to maintain a strong community of scholars dedicated to fostering dialogue and innovation in the organic sciences.

European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.

Chemistry Letters, published by the Chemical Society of Japan, is a distinguished academic journal that focuses on pivotal developments in the field of chemistry. Since its inception in 1973, the journal has been a vital platform for the dissemination of novel research findings across various sub-disciplines, encompassing both theoretical advancements and practical applications. As a testament to its significance in the community, Chemistry Letters has achieved a Category Quartile of Q2 in the 2023 ranking for miscellaneous Chemistry journals, reflecting its respected position among peers. Although it does not offer Open Access, the journal remains accessible through institutional subscriptions, thus ensuring a wide reach for its valuable content. With an active scope ranging from general chemistry topics to specialized studies, it is ideal for researchers, professionals, and students alike who seek to contribute to and expand their knowledge within this dynamic field. The journal continuously aims to promote excellence in chemical research, facilitating dialogue and collaboration among chemists worldwide.